Search Results - Dima M Qato

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    School closures and prescription medication use among children and adolescents before and during the COVID-19 pandemic in the USA, 2019–2022 by Dima M Qato, Andrew Shooshtari, Abeeha Mirza

    Published in BMJ Paediatrics Open (2024-08-01)
    Get full text
    Article


  2. 2

    Time to inclusion in clinical guidance documents for non-oncological orphan drugs and biologics with expedited FDA designations: a retrospective survival analysis by Dima M Qato, Ryan Rodriguez, Rachel Brunner, Samantha Spencer

    Published in BMJ Open (2021-12-01)
    Get full text
    Article


  3. 3

    Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review by Thomas Metkus, Jill Curran, Shanshan Lin, Dima M. Qato, G. Caleb Alexander

    Published in American Heart Journal Plus (2024-02-01)
    Get full text
    Article


  4. 4

    Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States by Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, Ransmond O. Berchie, Catherine G. Derington, Joshua A. Jacobs, Favel L. Mondesir, G. Caleb Alexander, Emily B. Levitan, Monika Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress

    Get full text
    Article


Search Tools: